WELL Health Technologies Corp.
WELL.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 64.57% | 54.21% | 55.18% | 23.64% | -1.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 64.57% | 54.21% | 55.18% | 23.64% | -1.33% |
| Cost of Revenue | 37.27% | 41.15% | 44.19% | 28.31% | 13.52% |
| Gross Profit | 114.80% | 73.44% | 71.49% | 17.22% | -20.47% |
| SG&A Expenses | 37.15% | 35.54% | 43.75% | 10.96% | 20.15% |
| Depreciation & Amortization | 6.82% | 50.27% | 45.12% | 10.88% | 21.59% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.86% | 40.01% | 44.12% | 21.20% | 16.43% |
| Operating Income | 160.80% | 3,098.42% | 33,508.21% | 142.58% | -726.80% |
| Income Before Tax | 301.53% | 107.41% | -77.14% | -457.07% | -126.05% |
| Income Tax Expenses | -81.25% | 346.39% | 191.64% | 52.69% | -997.99% |
| Earnings from Continuing Operations | 1,851.16% | 97.03% | -84.08% | -385.48% | -105.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -192.63% | 500.39% | -154.45% | -57.73% | 261.36% |
| Net Income | 185.81% | 104.58% | -88.41% | -498.07% | -71.90% |
| EBIT | 160.80% | 3,098.42% | 33,508.21% | 142.58% | -726.80% |
| EBITDA | 175.19% | 228.77% | 191.13% | 38.98% | -356.89% |
| EPS Basic | 149.81% | 104.48% | -88.73% | -486.87% | -69.76% |
| Normalized Basic EPS | 73.98% | 283.61% | 128.23% | 19.26% | -110.82% |
| EPS Diluted | 160.25% | 104.48% | -88.42% | -495.22% | -71.29% |
| Normalized Diluted EPS | 73.98% | 281.15% | 128.98% | 15.81% | -110.82% |
| Average Basic Shares Outstanding | 14.30% | 1.95% | 2.85% | 3.03% | -6.90% |
| Average Diluted Shares Outstanding | 14.30% | 3.38% | 0.91% | -1.09% | -6.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |